Borregaard ASA (BRGAY) Discusses BioSolutions Segment Outlook and Margin Dynamics Ahead of Close Transcript

Group 1 - The company expects Q4 sales volume in BioSolutions to be between 70,000 and 75,000 tonnes, which is a decrease from 77,000 tonnes in the same quarter last year [2] - There is an anticipated positive but limited effect from antidumping duties on vending [3] - Margin development in BioSolutions has shown a year-on-year decline, which was a core question raised during the Q&A session [3]